With the recent approval of Amylyx Pharmaceuticals’ drug Relyvrio, clinical trials for amyotrophic lateral sclerosis (ALS) are in the spotlight. Continual innovation is needed to ...
In the last several decades, public health research has illuminated the considerable racial and ethnic disparities in the diagnosis, treatment, and outcomes of many cancers. In ...
In this article, we will share how Referral Partner Interface streamlines clinical trial enrollment, improves clinical trial referral ROI for sponsors, and provides sites with a ...
Roughly 40% of adults suffer from functional gastrointestinal (GI) disorders worldwide. However, despite the prevalence of GI conditions, clinical trials for GI treatments are ...
Depending on the clinical trial phase, hundreds or even thousands of patients could be enrolled to test the efficacy and safety of a therapy. While that population may be spread ...
As of 2019, the average screen failure rate in global clinical trials stood at 36.3% across therapeutic areas. That’s nearly 2% higher than the average screen failure rate reported ...
.png?width=64&name=OST%20Transparent%20(1).png)
